| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |